Our previous studies have demonstrated that lung adenocarcinoma-intrinsic glycogen branching enzyme (GBE1) signaling regulates T cell infiltration and programmed cell death ligand 1 (PD-L1) expression in tumor cells; therefore, GBE1 may be a promising target for achieving tumor regression through cancer immunotherapy8. This evidence concerns the gene CD274 and cancer.